Press Releases

Webcast
Third Quarter 2020 Results Conference Call
Wednesday, November 04, 2020 4:30 pm EST

Third Quarter 2020 Results Conference Call
Wednesday, November 04, 2020 4:30 pm EST
Webcast Presentation

Click here for webcast

Keyword Search

Year None20202019201820172016201520142013

Date	Title
10/19/20	Sepsis Alliance Elects T2 Biosystems CEO as Advisory Board Member
10/14/20	T2 Biosystems to Report Third Quarter 2020 Financial Results on November 4, 2020
09/30/20	T2 Biosystems Announces BARDA Exercise of Contract Option 1 Valued at $10.5 Million
09/16/20	T2 Biosystems to Participate in Sepsis Alliance Summit
09/04/20	T2 Biosystems Announces CMS Approval of a New Technology Add-On Payment for the T2Bacteria® Panel for a Second Year
08/31/20	T2 Biosystems Receives FDA Emergency Use Authorization for COVID-19 Molecular Diagnostic Test
08/11/20	T2 Biosystems Announces Second Quarter 2020 Financial Results
08/05/20	T2 Biosystems Announces Withdrawal of Proxy Statement Proposal to Amend Its Certificate of Incorporation to Authorize a Possible Reverse Stock Split
07/30/20	T2 Biosystems to Participate in the Canaccord Genuity Annual Growth Conference
07/28/20	T2 Biosystems to Report Second Quarter 2020 Financial Results on August 11, 2020